Collector
  • X (Twitter)
Giriş Yap
Heart drug developer Kardigan is targeting a $1.4 billion valuation in its U.S. IPO | Collector
Heart drug developer Kardigan is targeting a $1.4 billion valuation in its U.S. IPO

Heart drug developer Kardigan is targeting a $1.4 billion valuation in its U.S. IPO

The Princeton, N.J., biotech plans to raise up to $373.3 million by selling 23.3 million shares priced between $14 and $16 each

Go to News Site